Conference Coverage: ASCO 2022 – Focus on GU

Impact of recent ASCO data on clinical practice and therapy guidance in genitourinary cancer.

June 10, 2022
Daniel Petrylak, MD, Yale, Aptitude Health

Faculty Chair

Daniel Petrylak, MD

Yale University, CT, US

FACULTY MEMBERS

Scott Tagawa, MD, FACP
Weill Cornell Medical Center

Thomas Powles, MD, MBBS, MRCP
Barts Cancer Institute

Robert Dreicer, MD, MACP, FASCO
University of Virginia Cancer Center

Emmanuel Antonarakis, MD
University of Minnesota Medical School

Karim Fizazi, MD, PhD
Institute Gustave Roussy

Susan Slovin, MD, PhD, FACP
Memorial Sloan Kettering Cancer Center

Leonard G. Gomella, MD, FACS
Jefferson University Hospitals

Oliver Sartor, MD
Tulane Cancer Center

Sample Report

Start discovering the insights

KEY TAKEAWAYS AND STRATEGIC INSIGHTS

A report will be produced based on the meeting, and will discuss the following topics

  • Novel Therapies for BCG-Unresponsive NMIBC and MIBC
  • Novel Agents for Metastatic Bladder Cancers
  • Metastatic Prostate Cancer – Hormonal Therapies and Imaging
  • Cytotoxic, Immune, and Targeted Therapies for Metastatic Prostate Cancer
  • Advanced Renal Cell Carcinoma
  • Renal Cell Carcinoma – Subgroup-Specific Therapies

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.